Exhibit 99.1
 | Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com |
February 4, 2025
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY) NSE
IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:
Date | Organized by | Location | Meeting mode | Nature of meet | Timing |
10.02.2025 | Avendus SPARK | Mumbai | In Person | Group meet | 11:00 am - 19:30 pm IST |
11.02.2025 | Avendus SPARK | Mumbai | In Person | Group meet | 08:30 am - 18:30 pm IST |
Please note that the schedule of the aforesaid meetings is subject to change due to any exigencies on the part of Investors / Company.
This is for your information.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited

K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR